Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | PSD | A5PKW4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14134133 | 0.98 | TDP1 (0.37) | TDP1L3MBTL1PSDALDH1A1MAPT | |
| SCHEMBL14134132 | 0.92 | TDP1 (0.35) | TDP1L3MBTL1PSDALDH1A1MAPT | |
| SCHEMBL14133096 | 0.91 | TDP1 (0.36) | TDP1L3MBTL1PSDALDH1A1MAPT | |
| SCHEMBL14134079 | 0.89 | AHR (0.36) | PSDALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL14133911 | 0.89 | TDP1 (0.33) | TDP1L3MBTL1PSDALDH1A1MAPT | |
| SCHEMBL14134089 | 0.88 | TDP1 (0.35) | TDP1L3MBTL1ALDH1A1MAPTHPGD | |
| SCHEMBL12770681 | 0.87 | SIGMAR1 (0.37) | PSDKDM4EGAAMEN1KMT2A | |
| SCHEMBL26335585 | 0.87 | TDP1 (0.35) | TDP1L3MBTL1HPGDDUSP3AHR | |
| SCHEMBL14134059 | 0.87 | ALOX5 (0.37) | PSDALDH1A1MAPTHPGDHSD17B10 | |
| SCHEMBL14133826 | 0.86 | TDP1 (0.34) | TDP1L3MBTL1DUSP3AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120299473-A1 | AMINOANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT FORMED USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120299473-A1 | AMINOANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT FORMED USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120299473-A1 | AMINOANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT FORMED USING SAME | CCNT1, ARL1, RFT1 | TDP1 980/4885L3MBTL1 437/4885PSD 4178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.